Modern tendencies in treatment of gastric cancer, complicated by peritoneal canceromatosis


Abstract

Modern tendencies in treatment of gastric cancer, complicated by peritoneal canceromatosis

References

1. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009 Aug 1;125(3):666-73. doi: 10.1002/ijc.24290.

2. Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010;2(2):85-97. doi: 10.4251/wjgo.v2.i2.85.

3. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000 Jan 15;88(2):358-63.

4. Yarema RR, Fetsych MT. Rak shlunka z vysokym ryzykom intraperytonealnoho prohresuvannia: faktory ryzyku ta rezultaty khirurhichnoho likuvannia. Klinichna onkolohiia. 2012;(5):33-6. [In Ukrainian].

5. Kim KW, Chow O, Parikh K, Blank S, Jibara G, Kadri H, et al. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy. Am J Surg. 2014 Jan;207(1):78-83. doi: 10.1016/j.amjsurg.2013.04.010.

6. Fanelli MF, de Paiva TF Jr, Silva MJ, Benevides CF, Guimarães AP, Gimenes DL, et al. Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil. J Surg Oncol. 2009 Nov 1;100(6):452-5. doi: 10.1002/jso.21349.

7. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003 Sep;90(9):1113-9.

8. Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; Extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol. 2000 Nov 75:165-71. doi:10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5.

9. Bozzetti F, Yu W, Baratti D, et al. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol. 2008;98:273-6. doi: 10.1002/jso.21052.

10. Yonemura Y, Endo Y, Yamaguchi T, Fujimura T, Obata T, Kawamura T, et al. Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol. 1996 Apr;8(4):795-802.

11. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area

of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 1994 Sep-Oct;14(5B):2131-4.

12. Stewart JH 4th, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005 Oct;12(10):765-77. doi: 10.1245/ASO.2005.12.001.

13. Yang QM, Kawamura T, Itoh H, Bando E, Nemoto M, Akamoto S, et al. Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology. 2008 Mar-Apr;55(82-83):782-5.

14. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A. ESMO Guidelines

Working Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v50-4. doi: 10.1093/annonc/mdq164.

15. Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazzaet J, et al. Staging and surgical approaches in gastric cancer: a clinical practice guideline. Curr Oncol. 2017;24(5):324-31. doi: 10.3747/co.24.3736.

16. Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol. 2011 Nov 1;104(6):692-8. doi: 10.1002/jso.22017..

17. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359-74

18. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004064. doi: 10.1002/14651858.CD004064.pub3.

19. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Oba K, Paoletti X, Bang YJ, Bleiberg H, Burzykowski T, Fuse N, et al. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer. 2013 May;49(7):1565-77. doi: 10.1016/j.ejca.2012.12.016.

20. Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg. 2010 Mar;34(3):555-62. doi: 10.1007/s00268-010-0396-5.

21. Kerkar SP, Kemp CD, Duffy A, Kammula US, Schrump DS, Kwong KF, et al. The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials. 2009 Dec 23;10:121. doi: 10.1186/1745-6215-10-121.

22. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995 Jan;221(1):29-42.

23. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998 Apr-May;14(3):254-61.

24. Roviello F, Caruso S, Marrelli D, Pedrazzani C, Neri A, De Stefano A, et al. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol. 2011 Mar;20(1):e38-54. doi: 10.1016/j.suronc.2010.09.002.

25. Huang JY, Xu YY, Sun Z, Zhu Z, Song YX, Guo PT, et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13(9):4379-85.

26. Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014 Sep;110(3):275-84. doi: 10.1002/jso.23633.

27. Yarema RR, Fetsych TG, Ohorchak MA, Zubarev GP, Oliynyk YY, Matusyak MB, et al. Intraoperatsiina hipertermichna vnutrishnocherevna khimioperfuziia v kombinovanomu likuvanni patsiientiv iz mistsevo-poshyrenym ta dyseminovanym rakom shlunka. Klinichna onkolohiia. 2013;(2):38-42. [In Ukrainian].

28. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal

carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010 Sep;17(9):2370-7. doi:10.1245/s10434-010-1039-7.

29. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology. 2001

Nov-Dec;48(42):1776-82.

30. Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer. 2001;4(1):27-33. doi: 10.1007/s101200100013.

31. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999 Feb 1;85(3):529-34.

32. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007 Oct;14(10):2702-13. doi: 10.1245/s10434-007-9487-4.

33. Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012 Nov 16;12:526. doi: 10.1186/1471-2407-12-526.

34. Hultman B, Lundkvist J, Glimelius B, Nygren P, Mahteme H. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta Oncol. 2012 Jan;51(1):112-21. doi: 10.3109/0284186X.2011.594809.

35. Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg. 1994 Jan-Feb;18(1):150-5.

36. Yu W, Whang I, Chung HY, Averbach A, Sugarbaker PH. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg. 2001 Aug;25(8):985-90.

37. Konstantinidis IT, Young C, Tsikitis VL, Lee E, Jie T, Ong ES. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience. World J Gastrointest Surg. 2012;4(6):135-40. doi: 10.4240/wjgs.v4.i6.135.

Author Biographies


O. I. Tkachenko, Оdessa National Medical University

Tkachenko Oleksandr Ivanovych; MD, DSc

Head of Department of Surgery N4 with a Course on Oncology;

Odessa National Medical University;

Valikhovsky Lane 2, Odessa, 65028, Ukraine

+380503366933

doctortkachenko@i.ua

https://orcid.org/0000-0001-7929-0220


V. Ye. Maksymovskyj, Оdessa National Medical University

Maksymovskyj Viacheslav Yevgenovych; MD, PhD;

Assistant of Department of Surgery N4 with a Course on Oncology

Odessa National Medical University;

Valikhovsky Lane 2, Odessa, 65028, Ukraine

+380503921484

maksidoc@gmail.com

https://orcid.org/0000-0001-5084-3290


D. M. Osadchyj, Оdessa National Medical University

Osadchyj Dmytro Mykolayovych; MD, PhD

Assistant of Department of Surgery N4 with a Course on Oncology;

Odessa National Medical University;

Valikhovsky Lane 2, Odessa, 65028, Ukraine

+380503901504

dmytros77@ukr.net

https://orcid.org/0000-0001-6421-6490


A. O. Mashukov, Оdessa National Medical University

Mashukov Artem Oleksiyovych; MD, PhD

Assistant of Department of Surgery N4 with a Course on Oncology;

Odessa National Medical University;

Valikhovsky Lane 2, Odessa, 65028, Ukraine

+380682560696

mashukster@gmail.com

https://orcid.org/0000-0001-6925-4218


A. I. Rybin, Оdessa National Medical University

Rybin Andrij Igorovych; MD, PhD;

Assistant of Department of Surgery N4 with a Course on Oncology

Odessa National Medical University

Valikhovsky Lane 2, Odessa, 65028, Ukraine

+38067852549

Andriy.Rybin@gmail.com

https://orcid.org/0000-0002-1145-6690


V. V. Pyrogov, Оdessa National Medical University

Pyrogov Vadym Vyacheslavovych;

Third-Year Intern; MBBS;

Odessa National Medical University;

+380972532008

motorid@ukr.net

https://orcid.org/0000-0001-7781-844X


V. V. Lysachenko, Оdessa National Medical University

Lysachenko Vladyslav Vasylyovych

Third-Year Intern; MBBS; Ukraine

Odessa National Medical University;

+380631301415

Megavlad481@gmail.com

https://orcid.org/0000-0002-1229-1752

Published
2019-01-30
How to Cite
Tkachenko, O. I., Maksymovskyj, V. Y., Osadchyj, D. M., Mashukov, A. O., Rybin, A. I., Pyrogov, V. V., & Lysachenko, V. V. (2019). Modern tendencies in treatment of gastric cancer, complicated by peritoneal canceromatosis. Klinicheskaia Khirurgiia, 85(1), 65-68. https://doi.org/10.26779/2522-1396.2019.01.65